1. Home
  2. NVCR vs CUBI Comparison

NVCR vs CUBI Comparison

Compare NVCR & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • CUBI
  • Stock Information
  • Founded
  • NVCR 2000
  • CUBI 1994
  • Country
  • NVCR Jersey
  • CUBI United States
  • Employees
  • NVCR N/A
  • CUBI N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • CUBI Major Banks
  • Sector
  • NVCR Health Care
  • CUBI Finance
  • Exchange
  • NVCR Nasdaq
  • CUBI Nasdaq
  • Market Cap
  • NVCR 1.8B
  • CUBI 1.4B
  • IPO Year
  • NVCR 2015
  • CUBI 2012
  • Fundamental
  • Price
  • NVCR $17.49
  • CUBI $46.46
  • Analyst Decision
  • NVCR Buy
  • CUBI Buy
  • Analyst Count
  • NVCR 5
  • CUBI 8
  • Target Price
  • NVCR $26.60
  • CUBI $63.86
  • AVG Volume (30 Days)
  • NVCR 1.3M
  • CUBI 290.2K
  • Earning Date
  • NVCR 10-30-2024
  • CUBI 10-31-2024
  • Dividend Yield
  • NVCR N/A
  • CUBI N/A
  • EPS Growth
  • NVCR N/A
  • CUBI 33.08
  • EPS
  • NVCR N/A
  • CUBI 7.41
  • Revenue
  • NVCR $549,964,000.00
  • CUBI $722,462,000.00
  • Revenue This Year
  • NVCR $16.23
  • CUBI N/A
  • Revenue Next Year
  • NVCR $6.09
  • CUBI $11.71
  • P/E Ratio
  • NVCR N/A
  • CUBI $6.12
  • Revenue Growth
  • NVCR 8.33
  • CUBI 25.87
  • 52 Week Low
  • NVCR $10.87
  • CUBI $38.69
  • 52 Week High
  • NVCR $24.74
  • CUBI $68.49
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 43.24
  • CUBI 48.18
  • Support Level
  • NVCR $15.61
  • CUBI $44.31
  • Resistance Level
  • NVCR $17.31
  • CUBI $47.11
  • Average True Range (ATR)
  • NVCR 1.29
  • CUBI 1.57
  • MACD
  • NVCR 0.05
  • CUBI 0.05
  • Stochastic Oscillator
  • NVCR 11.59
  • CUBI 28.96

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About CUBI Customers Bancorp Inc

Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources, and Financial Products and Services. The majority of revenue is derived from commercial lending.

Share on Social Networks: